Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joan E Walter"'
Autor:
Mirthe Dekker, Farahnaz Waissi, Joelle van Bennekom, Max J. M. Silvis, Nathalie Timmerman, Ingrid E. M. Bank, Joan E. Walter, Christian Mueller, A. H. Schoneveld, Raymond M. Schiffelers, Gerard Pasterkamp, Diederick E. Grobbee, Robbert J. de Winter, A. Mosterd, Dominique P. V. de Kleijn, Leo Timmers
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Diagnosing stable ischemic heart disease (IHD) is challenging, especially in females. Currently, no blood test is available. Plasma extracellular vesicles (EV) are emerging as potential biomarker source. We therefore aimed to identify stress
Externí odkaz:
https://doaj.org/article/59575484f3ea45c389f59fdfc9efc0c8
Autor:
Emma V. Troth, Matthew Ayala, Jessica Chadwick, Erin Hales, Michael Hinterberg, Jessica N. Kuzma, Clare Paterson, Rachel Ostroff, Joan E. Walter, Christian Mueller, Josef Coresh
Publikováno v:
Cancer Research. 83:4361-4361
Cardiovascular disease (CVD) is the most common non-cancer cause of death in cancer survivors and there is an unmet clinical need for easy, accurate, and safe CVD prognostic risk-stratification in adult cancer survivors. This study investigated wheth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26b4db34f6e50281cbd7a72cd95b0155
https://doi.org/10.1158/1538-7445.am2023-4361
https://doi.org/10.1158/1538-7445.am2023-4361
Autor:
Stephen A Williams, Rachel Ostroff, Michael Hinterberg, Josef Coresh, Christie M Ballantyne, Kunihiro Matsushita, Christian Mueller, Joan E Walter, Christian Jonasson, Rury H Holman, Svati H Shah, Naveed Sattar, Roy Taylor, Michael Lean, Shintaro Kato, Hiroaki Shimokawa, Yasuhito Sakata, Kotaro Nochioka, Chirag Parikh, Steven Coca, Torbjoern Omland, Jessica Chadwick, David Astling, Yolanda Hagar, Natasha Kurieski, Jeremy Primus, Missy Simpson, Nelson P Trujillo, Peter Ganz
Publikováno v:
Circulation. 144
Introduction: The critical path for novel treatment and prevention strategies, both pharmacological and non-pharmacological, requires clinical outcomes trials, which are slow, expensive and retard patient access to successful therapies. For marketed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91008c6dee80b4bb0a2343ba36cb2d76
https://doi.org/10.1161/circ.144.suppl_1.11537
https://doi.org/10.1161/circ.144.suppl_1.11537
Publikováno v:
Nature reviews. Clinical oncology. 18(3)
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint inhibitors has led to improved survival outcomes for patients with advanced-stage lung cancer; however, this disease remains the leading cause of cancer-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cdf9ff0fb857c43555fcb80ba79f2032
https://pubmed.ncbi.nlm.nih.gov/33046839
https://pubmed.ncbi.nlm.nih.gov/33046839